RightHealth

Posts Tagged ‘oseltamivir’

August 23, 2009

H1N1 Guidelines For Children »

As the start of another school year is upon us, parents are asking what to do should their children come down with symptoms of influenza. The World Health Organization just released updated guidelines with regards to children and the H1N1 (swine) flu. The current recommendation is prompt treatment for children who show severe or deteriorating illness, and those at risk of more severe or complicated disease. This includes all children under 5 years of age because this age group is at an increased risk of severe H1N1 infection. Children who are otherwise healthy and older than the age of 5 do not need to be given antiviral medication unless their illness persists or worsen. Most patients, including children, who are infected with the pandemic H1N1 virus will experience typical influenza symptoms and fully recover within a week, even without any form of medical treatment. The two antivirals currently used are oseltamivir and zanamivir. They can help to reduce disease severity and reduce the need for hospitalization. [via WHO]

Share your comments here.

Post to Twitter Tweet This Post to Facebook Share on Facebook

 
 
April 26, 2009

Swine Influenza Summary »

According to the US Centers for Disease Control and Prevention (CDC), as of April 26 there are 20 documented cases of swine influenza in the US. Swine influenza is a respiratory disease of pigs that can sometimes infect humans, who can then transmit it to other humans. The current strain of virus that is circulating among humans is the H1N1 strain. The latest laboratory testing shows that this strain is susceptible to the prescription antiviral drugs oseltamivir and zanamivir. The CDC has released guidelines on the use of these drugs, as well as how to take care of someone who is sick with the flu, available here. Also, see an interactive map of the locations of the outbreak.

Read more from the CDC. Share your opinion.

Post to Twitter Tweet This Post to Facebook Share on Facebook